Launa J. Aspeslet
Launa J. Aspeslet,
Chief Executive Officer
Dr. Launa J. Aspeslet joined TRIO in September 2014, took on the role of Chief Operating Officer in January 2015, and then became TRIO’s Chief Executive Officer in December 2015.
Before joining TRIO, Dr. Aspeslet was a biotechnology consultant working primarily with early stage companies to plan, implement, and follow through with the development strategy for their drug, device, or combination product. Prior to this, she was Chief Operating Officer for Isotechnika Pharma Inc., a former Edmonton biotechnology company. At Isotechnika, Dr. Aspeslet gained over 15 years of progressive management and leadership experience overseeing large operating budgets and 19 multiple-phase clinical trials.
Dr. Aspeslet has a depth of expertise in a wide range of fields including: strategic planning, quality assurance/control, clinical research, regulatory affairs, R&D in a medical/scientific setting, working with tight budgets/deadlines, negotiating international licensing partnerships, and publicly traded company matters.